Biochemical Engineering

Cambridge biotech makes diabetes breakthrough

Cambridge biotech makes diabetes breakthrough

21st September 2021

A small biotech company from Cambridgeshire has discovered a new way to deliver insulin, marking a technical breakthrough that could change the lives of people with type-two diabetes. Arecor, which was spun out of Unilever 14 years ago, has found a way to reformulate and stabilise insulin so that it can be administered at very high concentrations, but still be absorbed quickly into the body, a combination that, until now, has evaded scientists. Shares in Arecor surged by a third to 331p. Source: Daily Telegraph 21/9/2021


Back to group news